Results 241 to 250 of about 153,127 (306)
Association of Female Reproductive Factors with Incident Cardiometabolic Disease: Finding from a European Population-Based Study. [PDF]
Wang C +8 more
europepmc +1 more source
Recent highlights from the International Journal of Cardiology Heart & Vasculature: cardiometabolic disease. [PDF]
Bruns F, Märte H, Dobrev D, Fender A.
europepmc +1 more source
ABSTRACT Objective To determine associations between gestational diabetes mellitus (GDM) and body mass index (BMI) change between consecutive pregnancies, and hospital length of stay (LOS) and hospital costs. Design Retrospective cohort study. Setting Two maternity hospitals, New South Wales, Australia.
Rashidul Alam Mahumud +4 more
wiley +1 more source
Correction to: Macrophage energy metabolism in cardiometabolic disease. [PDF]
Wong A, Sun Q, Latif II, Karwi QG.
europepmc +1 more source
ABSTRACT Background The transition through menopause is accompanied by a series of adverse metabolic changes which are associated with an increased risk of cardiometabolic disease, a major cause of mortality in women after midlife. Whilst the indication for menopausal hormone replacement therapy (HRT) is the control of menopausal symptoms ...
Jiawen Dong +5 more
wiley +1 more source
Multi-organ network of cardiometabolic disease-depression multimorbidity revealed by phenotypic and genetic analyses of MR images. [PDF]
Wang J +18 more
europepmc +1 more source
Pregnancy Outcomes Among Individuals With Cerebral Palsy: A Population‐Based Cohort Study
ABSTRACT Objective To examine the risks of maternal, neonatal and non‐obstetrical medical complications in individuals with cerebral palsy (CP) compared to those without CP. Design Population‐based cohort study. Setting Ontario, Canada. Population Females aged 13–54 years with a livebirth or stillbirth, 2004–2023.
Marina Vainder +3 more
wiley +1 more source
A review of multidisciplinary care in metabolic dysfunction-associated steatohepatitis and cardiometabolic disease, with a focus on Canada. [PDF]
Kim J +5 more
europepmc +1 more source
ABSTRACT Background Psychotropic medications are associated with serious metabolic adverse effects, which contribute to an increased risk of cardiometabolic comorbidities in patients with severe mental illness (SMI). Several intervention strategies are available to mitigate these metabolic adverse effects; however, data on their utility in real‐world ...
Nicolette Stogios +17 more
wiley +1 more source

